Top in endocrinology: Diabetes and COVID-19, inflammatory markers and cognitive decline

A recent review of electronic health records showed that 4% of adults who were hospitalized with COVID-19 in the beginning of the pandemic were newly diagnosed with diabetes.

According to the study, about 40% of these newly diagnosed patients either returned to normoglycemia or prediabetes after 1 year. It was the top story in endocrinology last week.

The second top story looked at a study that found an association between systemic inflammatory markers and 10-year cognitive decline in adults aged 60 to 75 years with type 2 diabetes. Researchers found that higher levels of plasma interleukin-6, fibrinogen and C-reactive protein were associated with declines in executive function, abstract reasoning and processing speed.

Read these and more top stories in endocrinology below:

40% of new-onset diabetes during COVID-19 remitted at 1 year

Newly diagnosed diabetes was found in 4% of adults admitted to a U.S. hospital with COVID-19 early in the pandemic, and 40.6% of those patients returned to normoglycemia or prediabetes at 1 year, according to study data. Read more.

Baseline inflammatory markers predict 10-year cognitive decline in type 2 diabetes

At 10 years, higher baseline levels of systemic inflammatory markers, including plasma interleukin-6 and fibrinogen, were associated with greater cognitive decline for adults with type 2 diabetes, according to data. Read more.

Increase physical activity to reduce risk for diabetic neuropathy in type 1 diabetes

Adults with type 1 diabetes for 50 years or more are less likely to have distal symmetric polyneuropathy if they performed at least 150 minutes of physical activity weekly, according to study data. Read more.

Diabetes mortality decreased, with challenges in lower sociodemographic countries

An analysis published in The Lancet Diabetes & Endocrinology showed global progress in decreasing diabetes mortality in those younger than 25 years, with less pronounced reductions in low and low-middle sociodemographic countries. Read more.

Metabolic adaptation increases time to achieve weight-loss goals for premenopausal women

After a 16% weight loss, premenopausal women with overweight experienced metabolic adaptation associated with a longer time than predicted to achieve weight-loss goals, according to study results published in Obesity. Read more.